Chong Wee Foo, MD
Dermatology · Eugene, ORNPI 1588861058
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $242 of the $358 with a category attached, or 67.8%. 3 manufacturers reported payments, led by Novartis at 58.8% of the total. Reporting peaked in 2019 at $212 and has fallen 92.8% since, to $15 in 2023. That places this record below the midpoint for dermatology clinicians in OR, where the typical reported total is $1,330.
Across 10 payments — averaging $35.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$210
- Johnson & Johnson$132
- Pfizer$15
What the payments were for
- Food & beverage$24268%
- Education$11532%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $210 |
| Johnson & Johnson | 5 | $132 |
| Pfizer | 1 | $15 |
How this compares
$358 in reported general payments places this provider in the 30th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 33 | $123,854 |
| Doxycycline Monohydrate | 169 | $6,346 |
| Betamethasone Dipropionate | 72 | $4,054 |
| Triamcinolone Acetonide | 209 | $2,577 |
| Metronidazole | 51 | $2,106 |
| Fluorouracil | 22 | $1,808 |
| Fluocinonide | 22 | $1,672 |
| Clobetasol Propionate | 30 | $1,627 |
| Tacrolimus | 13 | $1,458 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 24 | $1,341 |
| Mycophenolate Mofetil | 13 | $1,222 |
| MethotrexateMethotrexate Sodium | 75 | $831 |
| Econazole Nitrate | 15 | $792 |
| Spironolactone | 32 | $607 |
| Terbinafine Hcl | 43 | $596 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Eugene
- Benjamin VazquezEugene$6K
- Diane BairdEugene$5K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.